Population Pharmacokinetics of Indinavir in Patients Infected with Human Immunodeficiency Virus

Indinavir is currently used at a fixed dose of 800 mg either three times a day or twice a day in combination with 100 mg of ritonavir. Dosage individualization based on plasma concentration monitoring might, however, be indicated. This study aimed to assess the pharmacokinetic profile of indinavir i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Csajka, Chantal, Marzolini, Catia, Fattinger, Karin, Décosterd, Laurent A., Telenti, Amalio, Biollaz, Jérôme, Buclin, Thierry
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2004
Schlagworte:
Pharmacology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC514769/
https://ncbi.nlm.nih.gov/pubmed/15328077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.9.3226-3232.2004
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge